Tessa Quax receives Beijerinck Premium
Tessa Quax of the Groningen Biomolecular Sciences and Biotechnology Institute (GBB) receives the Beijerinck Premium 2022 of the KNAW worth EUR 25,000 for her research on microbial virology. She will receive the premium at the Dutch Annual Virology Symposium on March 3, 2022. The Beijerinck Premium is awarded annually to a researcher who is at the beginning of his or her career and who is conducting outstanding virus-related research at a Dutch research institution.
Tessa Quax studies the mechanisms by which viruses infect microorganisms, the so called archaea. Archaea are single-celled organisms that, for example, occur in salt lakes and hot springs. Quax started her career at the Insitut Pasteur in Paris, where she conducted research on viruses from hot springs. Her passion for viruses and archaea led her to renowned research institutes in Belgium and Germany, where she specialized in molecular techniques to conduct research on archaea and their viruses. She has been an Associate Professor at the University of Groningen since 2021. Her research contributes to a better understanding of the role of viruses in nature and of the origin and evolution of viruses in general.
Recently, Tessa Quax also received an ERC Starting Grant and a KNAW Early Career Award.
Last modified: | 25 January 2022 1.02 p.m. |
More news
-
10 December 2024
Time will tell: what tree rings reveal about the past
Ancient DNA analysis of bones, teeth, or plants can reveal family connections, population movements, and domestication pathways. Pınar Erdil tells more about it.
-
09 December 2024
Error-free computer thanks to math and logic
Jorge Pérez, associate professor in Software Foundations at the University of Groningen, uses mathematics and logic on a quest towards a world free of software errors.
-
06 December 2024
26.9 million euros funding for CogniGron and HTRIC from Ubbo Emmius Fund
The Ubbo Emmius Fund (UEF) of the University of Groningen has awarded the Groningen Cognitive Systems and Materials Center and the Health Technology Research and Innovation Cluster a total of 26.9 million euros.